FILE – This Oct. 21, 2020 file photo shows Purdue Pharma headquarters in Stamford, Conn. Two members of the Sackler family have agreed to make a rare public appearance to take questions from a congressional committee that is investigating the role of the company they own, Purdue Pharma, in fueling the nation’s opioid epidemic. (AP Photo/Mark Lennihan, File)
OAN Newsroom
UPDATED 10:45 AM PT – Tuesday, December 15, 2020
Two former Purdue Pharma board members have agreed to testify before House panel that’s examining the origins of the opioid crisis.
The pair agreed to appear this coming Thursday after they were threatened with subpoenas last week by Rep. Carolyn Maloney (D-N.Y.). The two relatives are part of the Sackler family, which owns Purdue Pharma.
For decades, the Sackler family and Purdue Pharma fueled the opioid epidemic that claimed 400,000+ lives in the US. That’s why, last week, I threatened them with a subpoena and secured their first-ever public testimony. You can watch this Thursday’s @OversightDems hearing live ⤵️ https://t.co/60sdLc6E7X
— Carolyn B. Maloney (@RepMaloney) December 14, 2020
Purdue reportedly made around $30 billion solely from its sale of opioids. The company also plead guilty to giving illegal kickbacks to doctors and pharmacies in exchange for pushing patients to use opioids.
“Purdue was only one small piece of the opioid crisis. We know that, they started it,” stated Hunter Shkolnik, a class action attorney. “They were that little match out in the forest that starts a forest fire and they kept throwing gasoline on it.”
During Thursday’s hearing, Purdue will also outline the steps it is taking to address the opioid crisis.
RELATED: Purdue Pharma pleads guilty to misconduct fueling opioid crisis
Be the first to comment